Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Creative Medical Technology Holdings (CELZ) EBT Margin (2017 - 2025)

Historic EBT Margin for Creative Medical Technology Holdings (CELZ) over the last 9 years, with Q1 2025 value amounting to 54603.23%.

  • Creative Medical Technology Holdings' EBT Margin changed N/A to 54603.23% in Q1 2025 from the same period last year, while for Sep 2025 it was 99356.8%, marking a year-over-year decrease of 510115200.0%. This contributed to the annual value of 49940.74% for FY2024, which is 87989700.0% up from last year.
  • Per Creative Medical Technology Holdings' latest filing, its EBT Margin stood at 54603.23% for Q1 2025.
  • In the past 5 years, Creative Medical Technology Holdings' EBT Margin registered a high of 1786.07% during Q3 2022, and its lowest value of 61802.47% during Q4 2024.
  • Over the past 5 years, Creative Medical Technology Holdings' median EBT Margin value was 24232.53% (recorded in 2023), while the average stood at 28379.35%.
  • In the last 5 years, Creative Medical Technology Holdings' EBT Margin soared by 2000000000bps in 2021 and then tumbled by -276977800bps in 2022.
  • Over the past 5 years, Creative Medical Technology Holdings' EBT Margin (Quarter) stood at 5719.92% in 2021, then crashed by -484bps to 33417.7% in 2022, then crashed by -67bps to 55952.47% in 2023, then dropped by -10bps to 61802.47% in 2024, then grew by 12bps to 54603.23% in 2025.
  • Its EBT Margin was 54603.23% in Q1 2025, compared to 61802.47% in Q4 2024 and 19471.6% in Q2 2024.